Today’s news reports deal with such matters as:
- Advances in radical prostatectomy
- Variations in mutation in androgen-resistant patients
- Data from a Phase I/II trial of AT-101
- The link between CTC level and response to therapy with abiraterone … READ MORE …
Filed under: Drugs in development, Management, Treatment, Uncategorized | Tagged: abiraterone, androgen resistance, AT-101, CTC, ERG, mutation, radical prostatectomy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 